Statistics for CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

Total visits

views
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer 329

Total visits per month

views
January 2025 1
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0
July 2025 0

File Visits

views
Martin_CDH22.pdf 289

Top country views

views
United States 225
China 43
Germany 15
Ukraine 7
Spain 6
France 4
Sweden 4
Czechia 3
Romania 2
United Kingdom 1
India 1
Jordan 1
Netherlands 1
Singapore 1
Slovenia 1
Vietnam 1

Top city views

views
Ashburn 51
Fairfield 38
Wilmington 20
Houston 18
Ann Arbor 13
Norwalk 10
Cambridge 7
Nanjing 7
Beijing 6
Oakland 6
Dearborn 4
Jacksonville 4
Ningbo 4
Brno 3
Kunming 3
Logroño 3
Nanchang 3
Redmond 3
San Diego 3
Falls Church 2
Fremont 2
Guangzhou 2
Hangzhou 2
Hebei 2
Jinan 2
Mountain View 2
Santa Cruz 2
Shenyang 2
Tianjin 2
Zhengzhou 2
Changsha 1
Haikou 1
Hanoi 1
Hefei 1
Jiaxing 1
Las Palmas De Gran Canaria 1
Magdeburg 1
Menlo Park 1
Pamplona 1
Phoenix 1
Redwood City 1
Santa Clara 1
Shenzhen 1
Singapore 1
Tustin 1
Walnut 1
Woodbridge 1